A Phase 3 Randomized Safety and Efficacy Trial of HP802-247 in the Treatment of Chronic Venous Leg Ulcers (EU).

Trial Profile

A Phase 3 Randomized Safety and Efficacy Trial of HP802-247 in the Treatment of Chronic Venous Leg Ulcers (EU).

Discontinued
Phase of Trial: Phase III

Latest Information Update: 05 Oct 2016

At a glance

  • Drugs HP 802247 (Primary)
  • Indications Varicose ulcer
  • Focus Registrational; Therapeutic Use
  • Sponsors Smith & Nephew
  • Most Recent Events

    • 23 Feb 2015 Status changed from active, no longer recruiting to discontinued, according to ClinicalTrials.gov record.
    • 19 Nov 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
    • 30 Oct 2013 New source identified and integrated: ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top